Episodi
-
In this episode, learn how early and sustained HBV care can be enhanced by expanding the role of primary care providers in HBV management. Learn how to:
Engage key stakeholders in the provision of HBV careProvide HBV management resources to support PCPs who are doing screeningConsider specialty and primary care collaborations that empower PCPs with clear guidance on how to manage patients living with HBVPresenters:
Su Wang, MD, MPH, FACP
Medical Director
Center for Asian Health and Viral Hepatitis Programs
Cooperman Barnabas Medical Center
RWJBarnabas-Rutgers Medical Group
Associate Member
Health Care Policy and Aging Research
The Rutgers Institute for Health
Senior Advisor
Global Health, Hepatitis B Foundation
Florham Park, New JerseyRichard R. Andrews, MD, MPH
President, Houston Viral Hepatitis Task Force
Former Co-Chair, National Task Force on Hepatitis B
Board-Certified Family Medicine
Addiction Medicine Physician
Houston, TexasRuth Brogden, MPH
Patient AdvocateAmy S. Tang, MD
Former Co-Chair, National Task Force on Hepatitis B
Director of Immigrant Health
North East Medical Services
San Francisco, CaliforniaLink to full program:
https://bit.ly/3TuqFHILink to the slides:
https://bit.ly/44hXpHuGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
-
In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include:
Patient subgroups to consider for treatment outside guideline criteriaAdverse event and cost-effectiveness considerationsIntegration of patient perspectives in wider treatmentPresenters:
Mark S. Sulkowski, MD, FIDSA, FAASLD
Professor of Medicine
Director, Division of Infectious Diseases, Johns Hopkins Bayview Medical Center
Johns Hopkins University School of Medicine
Baltimore, MarylandTatyana Kushner, MD, MSCE
Associate Professor
Division of Liver Diseases
Icahn School of Medicine at Mount Sinai
New York, New YorkPaul Y. Kwo, MD
Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Palo Alto, CaliforniaJacki Chen, PhD
Patient AdvocateLink to full program:
https://bit.ly/3TuqFHILink to the slides:
https://bit.ly/4a60GM4Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
-
Episodi mancanti?
-
In this episode, Arun B. Jesudian, MD, and Mazen Noureddin, MD, MHSc, discuss the expert-informed clinical pathway for the multidisciplinary care of patients with MASLD or MASH, current and emerging therapeutics, and management optimization strategies.
Presenters:
Arun B. Jesudian, MD
Associate Professor of Clinical Medicine
Division of Gastroenterology and Hepatology
Weill Cornell Medicine
New York, New YorkMazen Noureddin, MD, MHSc
Professor of Medicine
Houston Methodist Hospital
Director
Houston Research Institute
Houston, TexasContent based on an online CME program supported by independent educational grants from Novo Nordisk.
To view the full program on “Clinical Pathways: Multidisciplinary Approach to Managing Metabolic Dysfunction‒Associated Steatohepatitis,” including 4 CME/CE-certified text modules with accompanying slidesets, 4 ClincalThought commentaries, and a downloadable infographic resource on the AGA MASLD MASH Clinical Care Pathway, visit clinicaloptions.com or click on the link below.
Link to full program:
https://bit.ly/3Tyu7At -
In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include:
Updated CDC recommendations for one-time universal screening for HBVAddressing patient-, provider-, and system-level barriers to universal HBV screeningBest practices for implementation of HDV screeningPresenters:
Douglas Dieterich, MD
Director, Institute for Liver MedicineProfessor of Medicine
Division of Liver Diseases
Mount Sinai School of Medicine
New York, New York
Camilla S. Graham, MD, MPH
Co-Director, Viral Hepatitis Clinic
Division of Infectious Diseases
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, MassachusettsRobert Wong, MD, MS
Clinical Associate Professor
Division of Gastroenterology and Hepatology
Stanford University School of Medicine
Palo Alto, CaliforniaLink to full program:
https://bit.ly/3TuqFHILink to the slides:
https://bit.ly/4atS42z -
In this episode, Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss strategies for managing ambulatory patients with acute or previous COVID-19 infection, including:
Current COVID-19 landscapeRapid antigen tests and PCR testsRisk stratification of patients who have a positive SARS-CoV-2 testAntiviral treatment (nirmatrelvir + ritonavir, remdesivir, and molnupiravir)Long COVIDPresenters:
Renslow Sherer, MD
Director, International HIV Training Center
Professor of Medicine
Section of Infectious Diseases and Global Health
Department of Medicine
University of Chicago
Chicago, IllinoisTrinh P. Vu, PharmD, BCIDP
Clinical Pharmacy Specialist in Infectious Diseases
Department of Pharmaceutical Services
Emory University Hospital Midtown
Atlanta, GeorgiaTo download the slides: bit.ly/3oHKC09
To view the full online program: bit.ly/4201xcO
-
In this episode, Jona Tanguay, MMSc, PA-C, AAHIVS discusses considerations to review with patients to empower them to make their own informed choices in PrEP selection, including:
Leveraging PrEP options with unique dosing schedules and/or routes such as long-acting cabotegravir and on-demand 2-1-1 FTC/TDFDifferences in adverse effect profiles between 4 PrEP optionsPotential for HIV resistanceRequirements for compliance and monitoringEvidence in populations with various acquisition behaviorsDrug interaction implicationsFaculty:
Jona Tanguay, MMSc, PA-C, AAHIVS
Health Care Provider and HIV Specialist
Whitman-Walker Health
Vice President for Education, GLMA: Health Professionals Advancing LGBTQ Equality
Clinical Instructor, Yale University School of Nursing
Washington, DC
Link to full program: https://bit.ly/41WF54o
-
In this episode, Dr. Parsons and Dr. Battista discuss current and emerging medical therapies for the treatment of spinal muscular atrophy (SMA). They review safety, efficacy, and monitoring parameters of current agents, as well as adjuct therapies in the medication pipeline. This high-level overview includes:
Review of FDA-approved medical therapies: nusinersen, onasemnogene abeparvovec-xioi, and risdiplamDiscussion of the safety, efficacy, and monitoring parameters for FDA approved medications, as well as adjuctive agents for medication therapy complicationsReview of ongoing clinical trials on anti-myostatin medications and discussion of the role these agents would play if approved by the FDAPresenters:
Julie Parsons, MD
Co-Director, Neuromuscular Clinic
Haberfeld Family Endowed Chair in Pediatric Neuromuscular Disorders
Professor of Clinical Pediatrics and Neurology
Children’s Hospital Colorado
Denver, ColoradoVanessa Battista, DNP, MBA, RN, MS, CPNP-PC, CHPPN, FPCN
Senior Director of Nursing, Palliative Care
Psychosocial Oncology and Palliative Care
Dana-Farber Cancer Institute
Boston, MassachusettsSupported by an educational grant from Biogen
Link to full program:
bit.ly/41kw2dKLink to CME: Claim credit -
bit.ly/40fkDKD -
In this episode, Julie Parsons, MD, discusses the genetic diagnosis of spinal muscular atrophy (SMA), anticipated clinical findings, the importance of newborn screenings, and the next steps to consider after a positive diagnosis is obtained. This high-level overview includes:
SMA as an autosomal recessive diseaseDifferences in spinal motor neurons (SMN) 1 and 2 at the time of diagnosis and how these drive severity of diseaseImportant clinical findings in the diagnosis of SMA, as every child may not be identified with newborn screeningThe importance of newborn screening and critical next steps and logistical considerations when receiving a positive screen in your practicePresenters:
Julie Parsons, MD
Co-Director, Neuromuscular Clinic
Haberfeld Family Endowed Chair in Pediatric Neuromuscular Disorders
Professor of Clinical Pediatrics and Neurology
Children’s Hospital Colorado
Denver, ColoradoVanessa Battista, DNP, MBA, RN, MS, CPNP-PC, CHPPN, FPCN
Senior Director of Nursing, Palliative Care
Psychosocial Oncology and Palliative Care
Dana-Farber Cancer Institute
Boston, MassachusettsSupported by an educational grant from Biogen
Link to full program:
bit.ly/41kw2dKLink to CME: Claim credit -
bit.ly/40eyBwr -
In this episode, Dr. Battista and Dr. Parsons discuss the importance of care guidelines and the multidisciplinary team in the treatment of spinal muscular atrophy (SMA). This overview will include:
The role each member of the interdisciplinary team plays in the care of SMA including physical therapists, occupational therapists, and speech therapistsThe importance of continued, ongoing therapy in addition to medication therapy to provide the greatest improvement in SMA careHow to manage transitions in care, including the transition from pediatrics to adulthood and how to include the necessary support teamsThe role shared decision-making plays in the treatment of patients with SMAPresenters:
Julie Parsons, MD
Co-Director, Neuromuscular Clinic
Haberfeld Family Endowed Chair in Pediatric Neuromuscular Disorders
Professor of Clinical Pediatrics and Neurology
Children’s Hospital Colorado
Denver, ColoradoVanessa Battista, DNP, MBA, RN, MS, CPNP-PC, CHPPN, FPCN
Senior Director of Nursing, Palliative Care
Psychosocial Oncology and Palliative Care
Dana-Farber Cancer Institute
Boston, MassachusettsSupported by an educational grant from Biogen.
Link to full program:
https://bit.ly/43Dmo7qLink to CME: Claim credit
https://bit.ly/40gulfX -
In this episode, Vikramjit Mukherjee, MD, and Cameron Smith, MPAS, PA-C, answer audience questions on how best to care for hospitalized patients with COVID-19 from a live, virtual question and answer webinar. This episode includes expert insights on:
Viral coinfections such as influenza and RSVNew data comparing baricitinib and tocilizumab for patients with severe COVID-19Management of bacterial and fungal coinfection while incorporating antimicrobial stewardshipTips for transitioning patients out of the ICU and to the medical floor or homePresenters:
Vikramjit Mukherjee, MD
Assistant Professor
Division of Pulmonary, Critical Care, & Sleep Medicine
New York University School of Medicine
Director
Medical Intensive Care Unit
Bellevue Hospital
New YorkCameron Smith MPAS, PA-C
Lead Advanced Practice Provider
Medical Intensive Care Unit
Bellevue Hospital
New York Health and Hospitals
New YorkContent based on an online program supported by an independent educational grant from Gilead Sciences, Inc. Link to full program:
bit.ly/3z52c00 -
In this episode, Vikramjit Mukherjee, MD, and Cameron Smith, MPAS, PA-C, answer audience questions on how best to care for hospitalized patients with COVID-19 from a live, virtual question and answer webinar. This episode includes expert insights on:
Supportive care management such as oxygen support, glycemic control, and anticoagulationEscalation of therapy in patients with worsening oxygen requirementsUse of remdesivir in patients with renal dysfunctionBrief commentary on long COVIDPresenters:
Vikramjit Mukherjee, MD
Assistant Professor
Division of Pulmonary, Critical Care, & Sleep Medicine
New York University School of Medicine
Director
Medical Intensive Care Unit
Bellevue Hospital
New YorkCameron Smith MPAS, PA-C
Lead Advanced Practice Provider
Medical Intensive Care Unit
Bellevue Hospital
New York Health and Hospitals
New York, New YorkContent based on an online program supported by an independent educational grant from Gilead Sciences, Inc.
bit.ly/3z52c00 -
In this podcast, Susan LeLacheur, DrPH, PA-C, AAHIVS discusses racial disparities in access to HIV prevention (PrEP) and strategies to close these gaps, including:
Incorporating comprehensive sexual history into medical appointments and offering PrEP to all sexually active patientsIncrease awareness of PrEP access programs in communities of colorDiversification of the medical workforceFaculty:
Susan LeLacheur, DrPH, PA-C, AAHIVS
Professor
Department of Physician Assistant Studies
School of Medicine and Health Sciences
The George Washington University
Washington, DC
Link to full program: https://practicingclinicians.com/content/hiv-prevention-resource-center
-
This podcast episode is part of a multimedia program reviewing the management of nontuberculous mycobacterial lung disease (NTM-LD). Tune in to hear Jennifer Faber-Gerling, RN, MS, CNS, ANP-BC, and Anne O’Donnell, MD, highlight the diagnostic criteria and optimal treatment strategies in patients with NTM-LD. The overview will include:
Recommended assessments and tests to appropriately diagnosis NTM-LD in patientsA summary of the current guidelines for the management of NTM-LD, including appropriate monitoring of medications.Guidance on how to individualize treatment plans for patients with NTM-LD based on disease and patient characteristicsPresenters:
Jennifer Faber-Gerling, RN, MS, CNS, ANP-BC
Nurse Practitioner
Division of Mycobacterial and Respiratory Infections
National Jewish Health
Denver, ColoradoAnne O’Donnell, MD
Professor of Medicine
Division of Pulmonary, Critical Care, and Sleep Medicine
Georgetown University Medical Center
Washington, DCTo view other program offerings, including a CE-certified on-demand webcast, a Q&A text module, and to download slides, visit
pce.is/NTM. -
In this episode, Tracy Zivin-Tutela, MD, answers audience questions on how best to care for patients at high risk of complications due to influenza from a live virtual meeting series. This episode includes expert insights on:
Emerging resistance patterns of currently used antiviralsGetting the flu vaccine after treatment with antiviralsUse of antivirals in patients who test positive for flu and COVID-19Techniques and over-the-counter therapies other than yearly vaccination to avoid severe complications due to the flu Avoiding dairy after receiving baloxavirInsurance coverage for antiviralsConsidering bacterial and viral coinfection in patients with lung diseaseRetreating high-risk patients with antivirals after another flu exposureCalculating flu ratesPresenter:
Tracy Zivin-Tutela, MD
Attending Physician
Division of Infectious Diseases
Department of Medicine
Los Alamitos Medical Center, Fountain Valley Regional Hospital
New Brunswick, CaliforniaDaniel Zalinov, PA-C
Atrium Health
Charlotte, North CarolinaLink to full program:
https://bit.ly/3GMokRC -
In this episode, Stephen Krieger, MD, and Allison Boyd, MPAS, PA-C, MSCSdiscuss timely recognition of MS, including insights into why early recognition can lead to early treatment, which can decrease the risk of disability progression and produces better outcomes. Challenges discussed include the variable clinical presentation of MS and the lack of specific tests. The experts also discuss how to avoid missed diagnosis and misdiagnosis.
Stephen Krieger, MD: consultant/advisor/speaker: Biogen, EMD Serono, Genentech, Genzyme/Sanofi, Novartis, Octave, TG Therapeutics; researcher: Biogen, Bristol-Myers Squibb, Novartis, Sanofi.
Allison L. Boyd, MPAS, PA-C, MSCS: consultant/advisor/speaker: EMD Serono.
-
In this episode, Stephen Krieger, MD, and Allison Boyd, MPAS, PA-C, MSCSdiscuss the expanding treatment armamentarium for MS, the complexities involved in making treatment selection, patient factors to consider when individualizing treatment, and how best to talk with patients about their options within the context of shared decision-making.
Stephen Krieger, MD: consultant/advisor/speaker: Biogen, EMD Serono, Genentech, Genzyme/Sanofi, Novartis, Octave, TG Therapeutics; researcher: Biogen, Bristol-Myers Squibb, Novartis, Sanofi.
Allison L. Boyd, MPAS, PA-C, MSCS: consultant/advisor/speaker: EMD Serono.
-
In this episode, Stephen Krieger, MD, and Allison Boyd, MPAS, PA-C, MSCS discuss the challenges of managing patients with MS over the long-term, including assessment and management of comorbidities management, differentiating relapse from pseudorelapse, telemedicine, and the important role of NPs and PAs in multidisciplinary care.
-
In this podcast, Jason E. Farley, PhD, MPH, ANP-BC shares his recommendations on the best ways to implement new HIV PrEP guidelines based on his clinical experiences.
-
In this podcast, Latesha Elopre, MD, MSPH, discusses how the new CDC recommendations on pre-exposure prophylaxis (PrEP) education, eligibility, and monitoring affect her clinical practice.
Contributors:
Latesha Elopre, MD, MSPH
Associate Professor
Division of Infectious Diseases
University of Alabama at Birmingham
Birmingham, AlabamaLatesha Elopre, MD, MSPH, has no relevant financial relationships to disclose.
-
In this podcast, Latesha Elopre, MD, MSPH and Jason Farley, PhD, MPH, ANP-BC, FAAN, AACRN answer pressing questions from healthcare professionals who care for patients that may be at risk for HIV infection.
Presenters:
Latesha Elopre, MD, MSPH
Associate Professor
Division of Infectious Diseases
University of Alabama at Birmingham
Birmingham, AlabamaModerator
Jason Farley, PhD, MPH, ANP-BC, FAAN AACRN
Endowed Professor of Nursing Leadership and Innovation
Johns Hopkins University School of Nursing
Director, Center for Infectious Disease and Nursing Innovation
Adult Nurse Practitioner, Infectious Diseases
Johns Hopkins Medicine
Baltimore, Maryland - Mostra di più
